New research explores how the psoriasis medication apremilast might benefit heart health by reducing epicardial fat tissue in patients.
Patients with psoriasis face more than just skin challenges. According to new research from the Journal of Investigative Dermatology, obesity significantly worsens psoriasis outcomes while increasing cardiovascular risks—a connection that may be addressed by certain treatments.
The study highlights how obesity isn't just associated with psoriasis but actively drives its severity. Researchers note that excess weight is linked to larger affected body surface areas, increased risk of developing psoriatic arthritis, and diminished response to biological treatments over time.
What makes this relationship particularly concerning is the specific type of fat that accumulates in people with psoriasis. According to the journal, patients tend to develop higher levels of visceral adipose tissue (VAT)—the metabolically active fat that surrounds internal organs rather than accumulating under the skin.
The Dangerous Connection Between Fat and Inflammation
This visceral fat isn't merely excess weight—it's biologically active tissue that promotes insulin resistance, abnormal cholesterol levels, systemic inflammation, and atherosclerosis (hardening of the arteries), according to the researchers.
The findings suggest that addressing obesity may be a crucial component of comprehensive psoriasis care. By recognizing the interconnection between weight, inflammation, and treatment efficacy, healthcare providers might better manage both the skin condition and its associated cardiovascular risks.
This research underscores the complexity of psoriasis as a systemic inflammatory condition rather than just a skin disease. For the albinism community, which already navigates unique skin health challenges, these insights into inflammatory skin conditions and their systemic effects offer valuable perspective on comprehensive health management.
As medical understanding of the relationship between skin conditions and overall health continues to evolve, integrated approaches that address both visible symptoms and underlying inflammation may benefit patients with various skin-related conditions.
Keywords
Core topics and entities mentioned in this summary.